BioWorks recently surpassed $100,000 in total lifetime contributions to American Floral Endowment in support of floriculture research and education.

Lunai Bioworks (NASDAQ: LNAI), an AI-powered biotech and biodefense company, was featured on CNBC's Business Minute. Company CEO David Weinstein shared how the company is using its proprietary AI ...

SACRAMENTO, Calif., Feb. 9, 2026 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, today announced the launch of a new oncology collaboration with a ...

Ginkgo Bioworks Holdings, Inc. (DNA) reached $9.23 at the closing of the latest trading day, reflecting a -9.06% change ...

Chemical recycling was validated step-by-step from laboratory scale to pilot scale. After optimizing conditions at the lab level, pilot-scale testing confirmed that high-purity, high-quality recycled ...

This engagement begins as a defined pilot, with a clear path to expand into a multi-study commercial relationship based on results. For Lunai, this is the kind of near-term work that can translate ...

Ginkgo's future may be promising, but whether the company can realize its potential is debatable. Special purpose acquisition companies (SPACs) were popular in 2021 while investors were buying up meme ...

Ginkgo Bioworks is aiming to play a key role in drug development. And there's a solid argument for why it could be hugely successful one day. But it'll need to become a lot more efficient as it scales ...

Could Ginkgo Bioworks Holdings (NYSE: DNA) one day be part of the healthcare sector's version of the "Magnificent Seven" group of high-performing stocks? It's more likely than you think. The ...